Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02983968
What this trial is testing

Use of the French Healthcare Insurance Database

Who this might be right for
Cirrhosis
Centre Hospitalier Universitaire, Amiens 75,868
Not applicableUnknownNCT05627297
What this trial is testing

Applying Artificial Intelligence to Optimize Early-stage Hepatocellular Carcinoma Treatment Based on Multi-modal Image

Who this might be right for
Hepatocellular Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 200
Not applicableStudy completedNCT06881433
What this trial is testing

Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhongda Hospital 1,649
Testing effectiveness (Phase 2)UnknownNCT04483284
What this trial is testing

Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 28
Large-scale testing (Phase 3)UnknownNCT05408221
What this trial is testing

The Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shandong New Time Pharmaceutical Co., LTD 576
Not applicableActive Not RecruitingNCT05657249
What this trial is testing

Alternative Surveillance Program for Patients With High Risk Group of HCC

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 199
Early research (Phase 1)Study completedNCT04358185
What this trial is testing

Itacitinib in Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Imperial College London 19
Testing effectiveness (Phase 2)Study completedNCT03199274
What this trial is testing

Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Thomas Jefferson University 104
Testing effectiveness (Phase 2)Study completedNCT03682276
What this trial is testing

Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Imperial College London 33
Large-scale testing (Phase 3)UnknownNCT03974074
What this trial is testing

Albumin for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHypoproteinemia
Guangxi Medical University 200
Large-scale testing (Phase 3)UnknownNCT03950518
What this trial is testing

Novel Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
HCC
The First Affiliated Hospital of Zhengzhou University 300
Not applicableStudy completedNCT04642547
What this trial is testing

Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaMolecular Targeted Therapy
RenJi Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07192848
What this trial is testing

Adebrelimab + Apatinib in Advanced HCC Post-Systemic Therapy

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Song Peng 47
Not applicableEnded earlyNCT01167374
What this trial is testing

Carbon Ion Radiotherapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University Hospital Heidelberg 21
Testing effectiveness (Phase 2)Looking for participantsNCT06349317
What this trial is testing

Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Yongyi Zeng 33
Testing effectiveness (Phase 2)Study completedNCT00005938
What this trial is testing

DX-8951f in Treating Patients With Biliary Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Daiichi Sankyo
Testing effectiveness (Phase 2)Looking for participantsNCT06309485
What this trial is testing

Phase 2 Study of WGI-0301 for Advanced HCC

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Zhejiang Haichang Biotech Co., Ltd. 60
Not applicableLooking for participantsNCT07079150
What this trial is testing

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

Who this might be right for
Hepatitis B, Chronic (CHB)Hepatitis BHepatitis B Virus (HBV)
First Affiliated Hospital Xi'an Jiaotong University 1,500
Testing effectiveness (Phase 2)UnknownNCT04368078
What this trial is testing

Lenvatinib Combined Toripalimab in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Peking Union Medical College Hospital 76
Not applicableStudy completedNCT00764140
What this trial is testing

Tumor Growth Factors in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital 400
Next Page